ASTELLAS PHARMA INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of YPH for the last quarter is 2.89 B EUR, and it's 5.32% higher compared to the previous quarter. The net income of Q2 24 is 224.37 M EUR.